IF 2.8 3区医学

Eye Pub Date : 2025-03-05 DOI: 10.1038/s41433-025-03680-x

Chen Chen, Haoming Gao, Xiuli Guo, Wei Wei

引用次数: 0

Sarcoidosis with granulomatous tattoo reaction and uveitis. 结节病伴肉芽肿性纹身反应和葡萄膜炎。

IF 2.8 3区医学

Eye Pub Date : 2025-03-05 DOI: 10.1038/s41433-025-03744-y

Varsha Pramil, Aravindhan Sriharan, Kendra Klein-Mascia

引用次数: 0

Kaleidoscope of ocular tuberculosis. 眼结核的万花筒。

IF 2.8 3区医学

Eye Pub Date : 2025-03-05 DOI: 10.1038/s41433-025-03740-2

Manu Sharma, Atul Arora, Vishali Gupta

引用次数: 0

Reply to 'Comment on: Benchmarking the performance of large language models in uveitis: a comparative analysis of ChatGPT-3.5, ChatGPT-4.0, Google Gemini, and Anthropic Claude3'. 回复“评论：对大型语言模型在葡萄膜炎中的性能进行基准测试：ChatGPT-3.5、ChatGPT-4.0、谷歌Gemini和Anthropic Claude3的比较分析”。

IF 2.8 3区医学

Eye Pub Date : 2025-03-05 DOI: 10.1038/s41433-025-03737-x

Fang-Fang Zhao, Han-Jie He, Jia-Jian Liang, Ling-Ping Cen

引用次数: 0

Correction: UK corneal surgeons' attitudes towards splitting donor corneas between multiple recipients. 更正：英国角膜外科医生对将供体角膜分给多个受者的态度。

IF 2.8 3区医学

Eye Pub Date : 2025-03-04 DOI: 10.1038/s41433-025-03695-4

Jamie A Yule, Virginija Vilkelyte, Shakeel Ahmad, Poonam Sharma, James Myerscough, Stephen Kaye, Harry W Roberts

引用次数: 0

Correction: Validation and optimization of smart eye camera as teleophthalmology device for the reduction of preventable and treatable blindness in Nigeria 纠正：验证和优化智能眼相机作为远程眼科设备，在尼日利亚减少可预防和可治疗的失明。

IF 2.8 3区医学

Eye Pub Date : 2025-03-03 DOI: 10.1038/s41433-025-03654-z

Ayodele Jacob Orugun, Mayor Orezime Atima, Ugbede Idakwo, Oyeronke Komolafe, Kehinde Kabir Oladigbolu, Elijah Peter, Halima Olufunmilola Abdulsalam, Emamoke Atima-Ayeni, Emeka John Dingwoke, Rohan Khemlani, Shintaro Nakayama, Eisuke Shimizu, Emmanuel Oluwadare Balogun

引用次数: 0

Subretinal hyperoleon: the bubble trouble. 视网膜下肿大：泡状病变。

IF 2.8 3区医学

Eye Pub Date : 2025-03-03 DOI: 10.1038/s41433-025-03729-x

Vinay Patil, Atul Arora, Vishali Gupta

引用次数: 0

Reversal of hypotony maculopathy following traumatic cyclodialysis: a ring of hope. 创伤性睫状体透析后黄斑低压性病变的逆转：希望之环。

IF 2.8 3区医学

Eye Pub Date : 2025-03-03 DOI: 10.1038/s41433-025-03701-9

Mohideen Abdul Kader, Madhavi Ramanatha Pillai, Rinkal Goyal, Allapitchai Fathima

引用次数: 0

Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP). 通过新加坡综合糖尿病视网膜病变计划（SiDRP）的摄影筛查预测糖尿病黄斑水肿的治疗需求。

IF 2.8 3区医学

Eye Pub Date : 2025-02-28 DOI: 10.1038/s41433-025-03725-1

Stanley S J Poh, Kelvin Y C Teo, Rose Ann Goh, Qian Xin Lee, Haslina Hamzah, Serene S C Sim, Colin S Tan, Ngiap Chuan Tan, Tien Yin Wong, Gavin S W Tan

{"title":"Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP).","authors":"Stanley S J Poh, Kelvin Y C Teo, Rose Ann Goh, Qian Xin Lee, Haslina Hamzah, Serene S C Sim, Colin S Tan, Ngiap Chuan Tan, Tien Yin Wong, Gavin S W Tan","doi":"10.1038/s41433-025-03725-1","DOIUrl":"10.1038/s41433-025-03725-1","url":null,"abstract":"Objective: To identify diabetic maculopathy features from photographic screening that are predictive of treatment on referral to a tertiary care centre.Methods: Retrospective review of participants who underwent screening by Singapore Integrated Diabetic Retinopathy Programme from 2015 to 2019. Participants underwent visual acuity (VA) test and non-stereoscopic retinal photographs. Maculopathy features include haemorrhages, microaneurysm and hard exudates (HE), stratified by inner and outer zone (1 and 1-2 disc diameter from fovea respectively) and VA of 6/12. Diabetic macular oedema (DMO) treatment was defined as intravitreal injection or macular photocoagulation up to 540 days from point of referral.Results: 16,712 patients screened had referable eye disease. Out of 3518 maculopathy suspects, 281 (8.0%) received DMO treatment within 540 days. Those treated for DMO had shorter duration of diabetes (6.90 vs. 9.13 years, p < 0.001), higher total cholesterol (4.65 ± 1.20 vs. 4.36 ± 1.13 mmol/L, p = 0.001) and LDL cholesterol (2.59 ± 1.05 vs. 2.37 ± 0.93 mmol/L, p < 0.05) than those without treatment. High-risk features, including inner zone haemorrhages with VA ≤ 6/12 (HR 12.0, 95% CI: 5.5-25.9) and inner zone hard exudates (HR 7.4, 95% CI: 3.4-15.8), significantly increased the likelihood of requiring DMO treatment compared to low-risk features. Higher body mass index is protective of DMO treatment in mild non-proliferative diabetic retinopathy (HR 0.84, 95% CI: 0.73-0.97).Conclusion: Haemorrhages, microaneurysms and HE within inner zone are important photographic features predictive of DMO treatment. VA is an important stratification for screening especially in patients with only visible haemorrhages.","PeriodicalId":12125,"journal":{"name":"Eye","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Atopic disease and astigmatism: a population-based study. 特应性疾病和散光：一项基于人群的研究

IF 2.8 3区医学

Eye Pub Date : 2025-02-28 DOI: 10.1038/s41433-025-03712-6

Margarita Safir, Itay Nitzan, Yair Hanina, Ari Safir, Eliya Levinger, Dan Heller, Nir Sorkin

{"title":"Atopic disease and astigmatism: a population-based study.","authors":"Margarita Safir, Itay Nitzan, Yair Hanina, Ari Safir, Eliya Levinger, Dan Heller, Nir Sorkin","doi":"10.1038/s41433-025-03712-6","DOIUrl":"10.1038/s41433-025-03712-6","url":null,"abstract":"Objectives: To assess the relationship between atopic disease and astigmatism in adolescence and young adulthood.Methods: In this population-based cross-sectional study 897,811 medical records of Israeli adolescents and young adults without keratoconus were reviewed. The prevalence of low-to-moderate (3.00 > D ≥ 0.75) and high ( ≥ 3.00 D) astigmatism were calculated in cases with and without atopic disease, including ocular atopic disease (OAD), asthma, allergic rhinitis, atopic dermatitis, angioedema/urticaria, and history of anaphylaxis. Relationships were analysed using multinominal logistic regression, with adjustments for relevant sociodemographic factors.Results: A total of 897,811 adolescents were included in the analysis (mean age 17.2 ± 0.8 years, 57.8% men). OAD was found in 4702 individuals, with a prevalence of 0.5%. Adolescents with OAD demonstrated a gradual increase in odds ratio (OR) for low-to-moderate and for high astigmatism (OR 1.16, 95% CI 1.07-1.27 and OR 2.10, 95% CI 1.63-2.70, respectively). This group also showed increased OR for with-the-rule astigmatism (OR 1.34, 95% CI 1.21-1.48). Other atopic diseases were associated with more modest ORs for low-to-moderate (OR 1.09, 95% CI 1.07-1.11) and for high astigmatism (OR 1.10, 95% CI 1.02-1.19), persisting across all axis orientations. Sensitivity analysis revealed a dose-response relationship between OAD severity and astigmatism, and consistent point estimates in a group of 1331 adolescents diagnosed with OAD during military service.Conclusions: This study establishes an association between OAD and astigmatism, highlighting the importance of effective OAD management. Further research into tailored therapeutic interventions that address both conditions concurrently is needed.","PeriodicalId":12125,"journal":{"name":"Eye","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Eye最新文献